CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AC4. A total of 24 filers reported holding CLOVIS ONCOLOGY INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $433,000 | 0.0% | 605,000 | 0.0% | 0.00% | – |
| Q2 2022 | $433,000 | -2.7% | 605,000 | 0.0% | 0.00% | – |
| Q1 2022 | $445,000 | +6.0% | 605,000 | 0.0% | 0.00% | – |
| Q4 2021 | $420,000 | +6.9% | 605,000 | 0.0% | 0.00% | – |
| Q3 2021 | $393,000 | -12.5% | 605,000 | 0.0% | 0.00% | – |
| Q2 2021 | $449,000 | -2.4% | 605,000 | 0.0% | 0.00% | – |
| Q1 2021 | $460,000 | +7.5% | 605,000 | 0.0% | 0.00% | – |
| Q4 2020 | $428,000 | +6.2% | 605,000 | 0.0% | 0.00% | – |
| Q3 2020 | $403,000 | +9.5% | 605,000 | 0.0% | 0.00% | – |
| Q2 2020 | $368,000 | -2.4% | 605,000 | 0.0% | 0.00% | – |
| Q1 2020 | $377,000 | -10.2% | 605,000 | -7.6% | 0.00% | – |
| Q4 2019 | $420,000 | +20900.0% | 655,000 | +13000.0% | 0.00% | – |
| Q3 2019 | $2,000 | -99.6% | 5,000 | -99.4% | 0.00% | – |
| Q2 2019 | $489,000 | -21.6% | 799,000 | 0.0% | 0.00% | – |
| Q1 2019 | $624,000 | -75.6% | 799,000 | -75.8% | 0.00% | – |
| Q3 2018 | $2,560,000 | – | 3,299,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|